OpenAps already has an app to guide CHO dose adjustment in the setting of hypoglycemia for users of their system.23 This situation-specific guidance on CHO treatment is a valuable tool and should be considered for incorporation into commercially available insulin delivery systems. This evidence concerns the gene INS and Hypoglycemia.